Overall, this study uncovers a novel regulatory circuitry involving TrkB–STAT3–miR-204-5p that is critical to the tumorigenicity of human endometrial carcinoma and indicates that reestablishing miR-204-5p expression could be explored as a potential new therapy for this disease. Here, STAT3 is linked to endometrial carcinoma.